Investing.com's Stocks of the Week

This week, various significant stock movements have occurred due to differing factors. Here are some highlights:

Disney (NYSE:DIS)

Disney shares have seen an upward trend for most of November, culminating in a 6.2% increase on Thursday following the release of its latest quarterly earnings. Investors were pleased with the company's streaming growth and future outlook.

As of Friday (12:40 pm ET), Disney shares are trading above $113. Analysts at Morgan Stanley have raised their target for the stock from $110 to $125, maintaining an Overweight rating. They noted that new guidance anticipates growth from a content turnaround and increasing investments in experiences. If successful, Disney could provide consistent double-digit adjusted EPS growth as it revitalizes and monetizes its iconic brands.

MicroStrategy

MicroStrategy's stock surged more than 25% on Monday after announcing it had increased its Bitcoin holdings, acquiring approximately 27,200 bitcoins for around $2.03 billion at an average price of about $74,463 per bitcoin. This acquisition boosts the company’s exposure to Bitcoin amid improving market sentiment surrounding potential favorable regulation in the industry. Bitcoin reached new all-time highs this week, peaking above $93,000 on Wednesday, before settling around $89,500 on Friday.

Vaccine Stocks

Shares of major vaccine manufacturers, including Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA), dropped sharply on Friday after President-elect Donald Trump nominated Robert F. Kennedy Jr. as his pick for Secretary of Health and Human Services (HHS). The announcement led to a sell-off, with Pfizer falling over 4% and Moderna declining by more than 6%. The broader SPDR S&P Biotech ETF also fell over 4%. Investors are concerned about future public health policy due to Kennedy’s background of vaccine skepticism and criticism of the FDA, which he has pledged to reform.